12 Comments
User's avatar
TomD's avatar

I stumbled upon both Vinay and Marty Makary in the COVID years. Two of very few docs or scientists that were making any sense in that crazy world. Not surprised at big pharma pushback. Finally, two people who won't be bought off by big pharma and will continue to push for RCTs before unleashing a drug on us. Keep up the great work

Expand full comment
Dan's avatar

Really? Pushing for RCT's doesn't make them happen.

Makary and Prasad along with Kennedy aren't making America healthy.

Here's a quote from Due Diligence and Art:

As of mid-March, 12.8% of kids 6 months to 17 years old got the updated Covid vaccine, according to CDC data. This means approximately 9 million children got poisoned with mRNA under Kennedy, Makary and Prasad’s watch.

Not much has changed at the FDA.

Expand full comment
TomD's avatar

Gee, Dan, let's see, Trump was sworn in on January 20 and less than 2 months later you expect major changes. Not sure when Vinay and Marty joined but they had certainly been in office for maybe 45 days in mid March. Major changes take time.

Expand full comment
Dan's avatar

Vinay's gone.... what's that tell you? They don't want anyone in there that might try to change things.

Expand full comment
Dan's avatar

Yeah, get back to me in a couple years and see if your saviour has made any major changes. The system is corrupted, until you change the system it doesn't matter who's sworn in or how much time expires. Pharma money rules!

Expand full comment
Michael Stewart's avatar

I’ve followed Vinay for years and just subscribed to his substack page to show my support.

I also, subscribed to yours as well.

Keep sharing the truth and for all those watching, it is time to show your support by subscribing to both Kevin and Vinay.

Note: I am a reader and not financially compensated in any way by Kevin nor Vinay.

Expand full comment
H8SBAD's avatar

Vinay is smart, principled, and compassionate. Phuck Pharma.

Expand full comment
dave's avatar

I find it interesting that the debunkers of a drug given to over 900 boys is declared ineffective based on a 48 week trial in boys aged about 7 years old - when they are just starting to fail. Yet you self-righteous debunkers never - and I mean never - check to see how those 900 boys are doing after actually getting the 3 million dollar shot. i haven't heard even one parent or kid say the drug has not helped. But you guys never even think to check. Speaks volumes as to how "scientific" you snarky "writers" (propagandists) really are.

Expand full comment
dave's avatar

Why not just take the time to investigate the extension part of the trial. Results were released 7 months ago. Continued improvement. As time passed the Elevidys kids left the control in the dust. undosed kids get worse and worse, Elevidys kids are stable or actually improve. You wasted so much time ranting ad raving over very old data. Admit it. Do't be so lazy.

https://www.neurologylive.com/view/elevidys-gene-therapy-demonstrates-sustained-benefits-disease-stabilization-duchenne-part-2-embark-results

Expand full comment
Alex Cranberg's avatar

It seems that Prasad would add and not subtract regulatory burden. The FDA shouldn't be shoving drugs prematurely but I'm sure that it must also be prone to excess caution...

This is the other voice:

https://www.wsj.com/opinion/vinay-prasad-leaves-fda-marty-makary-sarepta-duchenne-therapy-91690929?st=rmPRGL&reflink=article_copyURL_share

Expand full comment
FPD72's avatar

Attacking Dr. Prasad for previous left-of-center political statements that have nothing to do with the FDA is similar to the attacks on Tulsi Gabbard by National Review for being pro-abortion (I’m pro-life) when she was nominated for the DNI position, a position that has nothing to do with abortion.

I wouldn’t leap to the conclusion that Loomer’s attacks are prompted by Pharma; she seems to be motivated by a desire to keep the Trump administration free of leftists of any stripe and herself in the spotlight. The reality is that will take people of different persuasions to MAHA.

I gave up trying to understand the WSJ’s motives a long time ago and my subscription a year ago. That Bret Stephens could leave the WSJ and fit in seamlessly at the NYT and MSNBC says much.

Side question: in your battle with the Texas Tech administration, did you ever try to reach out to Cody Campbell, Dusty Wombel, or Terry Fuller?

Expand full comment